nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—Cardiovascular insufficiency—Thiotepa—sarcoma	0.113	0.113	CcSEcCtD
Pentazocine—Induration—Etoposide—sarcoma	0.0245	0.0245	CcSEcCtD
Pentazocine—Nystagmus—Vincristine—sarcoma	0.019	0.019	CcSEcCtD
Pentazocine—Ulcer—Dactinomycin—sarcoma	0.016	0.016	CcSEcCtD
Pentazocine—Ulcer—Mitoxantrone—sarcoma	0.0139	0.0139	CcSEcCtD
Pentazocine—Apnoea—Etoposide—sarcoma	0.0129	0.0129	CcSEcCtD
Pentazocine—Ulcer—Etoposide—sarcoma	0.0116	0.0116	CcSEcCtD
Pentazocine—Urinary retention—Thiotepa—sarcoma	0.0105	0.0105	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00991	0.00991	CcSEcCtD
Pentazocine—Urinary retention—Vincristine—sarcoma	0.00935	0.00935	CcSEcCtD
Pentazocine—Nystagmus—Epirubicin—sarcoma	0.00861	0.00861	CcSEcCtD
Pentazocine—Sweating increased—Mitoxantrone—sarcoma	0.00806	0.00806	CcSEcCtD
Pentazocine—Agranulocytosis—Thiotepa—sarcoma	0.00797	0.00797	CcSEcCtD
Pentazocine—Nystagmus—Doxorubicin—sarcoma	0.00796	0.00796	CcSEcCtD
Pentazocine—Agranulocytosis—Dactinomycin—sarcoma	0.00791	0.00791	CcSEcCtD
Pentazocine—Hallucination—Thiotepa—sarcoma	0.00763	0.00763	CcSEcCtD
Pentazocine—Sweating—Vincristine—sarcoma	0.00726	0.00726	CcSEcCtD
Pentazocine—Erythema multiforme—Dactinomycin—sarcoma	0.0072	0.0072	CcSEcCtD
Pentazocine—Cramp muscle—Etoposide—sarcoma	0.00717	0.00717	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00717	0.00717	CcSEcCtD
Pentazocine—Tinnitus—Thiotepa—sarcoma	0.00715	0.00715	CcSEcCtD
Pentazocine—Sweating—Mitoxantrone—sarcoma	0.00707	0.00707	CcSEcCtD
Pentazocine—Flushing—Dactinomycin—sarcoma	0.00706	0.00706	CcSEcCtD
Pentazocine—Agranulocytosis—Mitoxantrone—sarcoma	0.00688	0.00688	CcSEcCtD
Pentazocine—Chills—Thiotepa—sarcoma	0.00688	0.00688	CcSEcCtD
Pentazocine—Chills—Dactinomycin—sarcoma	0.00683	0.00683	CcSEcCtD
Pentazocine—Hallucination—Vincristine—sarcoma	0.00677	0.00677	CcSEcCtD
Pentazocine—Sweating increased—Etoposide—sarcoma	0.0067	0.0067	CcSEcCtD
Pentazocine—Ulcer—Epirubicin—sarcoma	0.0065	0.0065	CcSEcCtD
Pentazocine—Vision blurred—Thiotepa—sarcoma	0.00629	0.00629	CcSEcCtD
Pentazocine—Agitation—Thiotepa—sarcoma	0.00613	0.00613	CcSEcCtD
Pentazocine—Ulcer—Doxorubicin—sarcoma	0.00601	0.00601	CcSEcCtD
Pentazocine—Chills—Mitoxantrone—sarcoma	0.00594	0.00594	CcSEcCtD
Pentazocine—Hypertension—Thiotepa—sarcoma	0.00576	0.00576	CcSEcCtD
Pentazocine—Agranulocytosis—Etoposide—sarcoma	0.00573	0.00573	CcSEcCtD
Pentazocine—Dysgeusia—Mitoxantrone—sarcoma	0.00564	0.00564	CcSEcCtD
Pentazocine—Confusional state—Thiotepa—sarcoma	0.00549	0.00549	CcSEcCtD
Pentazocine—Agitation—Vincristine—sarcoma	0.00544	0.00544	CcSEcCtD
Pentazocine—Vision blurred—Mitoxantrone—sarcoma	0.00543	0.00543	CcSEcCtD
Pentazocine—Vertigo—Vincristine—sarcoma	0.00532	0.00532	CcSEcCtD
Pentazocine—Tachycardia—Thiotepa—sarcoma	0.00532	0.00532	CcSEcCtD
Pentazocine—Erythema multiforme—Etoposide—sarcoma	0.00521	0.00521	CcSEcCtD
Pentazocine—Anorexia—Thiotepa—sarcoma	0.00519	0.00519	CcSEcCtD
Pentazocine—Anorexia—Dactinomycin—sarcoma	0.00515	0.00515	CcSEcCtD
Pentazocine—Flushing—Etoposide—sarcoma	0.00511	0.00511	CcSEcCtD
Pentazocine—Hypertension—Vincristine—sarcoma	0.00511	0.00511	CcSEcCtD
Pentazocine—Hepatic function abnormal—Epirubicin—sarcoma	0.00511	0.00511	CcSEcCtD
Pentazocine—Hypertension—Mitoxantrone—sarcoma	0.00498	0.00498	CcSEcCtD
Pentazocine—Chills—Etoposide—sarcoma	0.00494	0.00494	CcSEcCtD
Pentazocine—Paraesthesia—Thiotepa—sarcoma	0.00489	0.00489	CcSEcCtD
Pentazocine—Somnolence—Thiotepa—sarcoma	0.00484	0.00484	CcSEcCtD
Pentazocine—Anaphylactic shock—Vincristine—sarcoma	0.00483	0.00483	CcSEcCtD
Pentazocine—Confusional state—Mitoxantrone—sarcoma	0.00474	0.00474	CcSEcCtD
Pentazocine—Decreased appetite—Thiotepa—sarcoma	0.00474	0.00474	CcSEcCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—sarcoma	0.00473	0.00473	CcSEcCtD
Pentazocine—Anaphylactic shock—Mitoxantrone—sarcoma	0.0047	0.0047	CcSEcCtD
Pentazocine—Decreased appetite—Dactinomycin—sarcoma	0.0047	0.0047	CcSEcCtD
Pentazocine—Dysgeusia—Etoposide—sarcoma	0.0047	0.0047	CcSEcCtD
Pentazocine—Hyperhidrosis—Vincristine—sarcoma	0.00467	0.00467	CcSEcCtD
Pentazocine—Constipation—Thiotepa—sarcoma	0.00466	0.00466	CcSEcCtD
Pentazocine—Shock—Mitoxantrone—sarcoma	0.00463	0.00463	CcSEcCtD
Pentazocine—Muscle spasms—Etoposide—sarcoma	0.00461	0.00461	CcSEcCtD
Pentazocine—Anorexia—Vincristine—sarcoma	0.0046	0.0046	CcSEcCtD
Pentazocine—Tachycardia—Mitoxantrone—sarcoma	0.00459	0.00459	CcSEcCtD
Pentazocine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00455	0.00455	CcSEcCtD
Pentazocine—Hypotension—Vincristine—sarcoma	0.00451	0.00451	CcSEcCtD
Pentazocine—Feeling abnormal—Thiotepa—sarcoma	0.00449	0.00449	CcSEcCtD
Pentazocine—Anorexia—Mitoxantrone—sarcoma	0.00448	0.00448	CcSEcCtD
Pentazocine—Diplopia—Epirubicin—sarcoma	0.00446	0.00446	CcSEcCtD
Pentazocine—Feeling abnormal—Dactinomycin—sarcoma	0.00446	0.00446	CcSEcCtD
Pentazocine—Hypotension—Mitoxantrone—sarcoma	0.0044	0.0044	CcSEcCtD
Pentazocine—Insomnia—Vincristine—sarcoma	0.00437	0.00437	CcSEcCtD
Pentazocine—Paraesthesia—Vincristine—sarcoma	0.00434	0.00434	CcSEcCtD
Pentazocine—Face oedema—Epirubicin—sarcoma	0.00431	0.00431	CcSEcCtD
Pentazocine—Vertigo—Etoposide—sarcoma	0.00431	0.00431	CcSEcCtD
Pentazocine—Paraesthesia—Mitoxantrone—sarcoma	0.00422	0.00422	CcSEcCtD
Pentazocine—Loss of consciousness—Etoposide—sarcoma	0.00421	0.00421	CcSEcCtD
Pentazocine—Decreased appetite—Vincristine—sarcoma	0.0042	0.0042	CcSEcCtD
Pentazocine—Dyspnoea—Mitoxantrone—sarcoma	0.00419	0.00419	CcSEcCtD
Pentazocine—Somnolence—Mitoxantrone—sarcoma	0.00418	0.00418	CcSEcCtD
Pentazocine—Hypertension—Etoposide—sarcoma	0.00414	0.00414	CcSEcCtD
Pentazocine—Constipation—Vincristine—sarcoma	0.00413	0.00413	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—sarcoma	0.00413	0.00413	CcSEcCtD
Pentazocine—Decreased appetite—Mitoxantrone—sarcoma	0.00409	0.00409	CcSEcCtD
Pentazocine—Constipation—Mitoxantrone—sarcoma	0.00402	0.00402	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00402	0.00402	CcSEcCtD
Pentazocine—Hypersensitivity—Thiotepa—sarcoma	0.00401	0.00401	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—sarcoma	0.00399	0.00399	CcSEcCtD
Pentazocine—Hypersensitivity—Dactinomycin—sarcoma	0.00398	0.00398	CcSEcCtD
Pentazocine—Confusional state—Etoposide—sarcoma	0.00395	0.00395	CcSEcCtD
Pentazocine—Anaphylactic shock—Etoposide—sarcoma	0.00391	0.00391	CcSEcCtD
Pentazocine—Asthenia—Thiotepa—sarcoma	0.00391	0.00391	CcSEcCtD
Pentazocine—Asthenia—Dactinomycin—sarcoma	0.00388	0.00388	CcSEcCtD
Pentazocine—Feeling abnormal—Mitoxantrone—sarcoma	0.00388	0.00388	CcSEcCtD
Pentazocine—Pruritus—Thiotepa—sarcoma	0.00385	0.00385	CcSEcCtD
Pentazocine—Tachycardia—Etoposide—sarcoma	0.00382	0.00382	CcSEcCtD
Pentazocine—Eosinophilia—Epirubicin—sarcoma	0.00382	0.00382	CcSEcCtD
Pentazocine—Hyperhidrosis—Etoposide—sarcoma	0.00378	0.00378	CcSEcCtD
Pentazocine—Anorexia—Etoposide—sarcoma	0.00373	0.00373	CcSEcCtD
Pentazocine—Diarrhoea—Thiotepa—sarcoma	0.00373	0.00373	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00372	0.00372	CcSEcCtD
Pentazocine—Diarrhoea—Dactinomycin—sarcoma	0.0037	0.0037	CcSEcCtD
Pentazocine—Hypotension—Etoposide—sarcoma	0.00366	0.00366	CcSEcCtD
Pentazocine—Dizziness—Thiotepa—sarcoma	0.0036	0.0036	CcSEcCtD
Pentazocine—Hypersensitivity—Vincristine—sarcoma	0.00356	0.00356	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—sarcoma	0.00353	0.00353	CcSEcCtD
Pentazocine—Paraesthesia—Etoposide—sarcoma	0.00351	0.00351	CcSEcCtD
Pentazocine—Dyspnoea—Etoposide—sarcoma	0.00349	0.00349	CcSEcCtD
Pentazocine—Somnolence—Etoposide—sarcoma	0.00348	0.00348	CcSEcCtD
Pentazocine—Hypersensitivity—Mitoxantrone—sarcoma	0.00347	0.00347	CcSEcCtD
Pentazocine—Asthenia—Vincristine—sarcoma	0.00347	0.00347	CcSEcCtD
Pentazocine—Vomiting—Thiotepa—sarcoma	0.00346	0.00346	CcSEcCtD
Pentazocine—Vomiting—Dactinomycin—sarcoma	0.00344	0.00344	CcSEcCtD
Pentazocine—Dermatitis—Thiotepa—sarcoma	0.00343	0.00343	CcSEcCtD
Pentazocine—Headache—Thiotepa—sarcoma	0.00341	0.00341	CcSEcCtD
Pentazocine—Decreased appetite—Etoposide—sarcoma	0.0034	0.0034	CcSEcCtD
Pentazocine—Asthenia—Mitoxantrone—sarcoma	0.00338	0.00338	CcSEcCtD
Pentazocine—Constipation—Etoposide—sarcoma	0.00335	0.00335	CcSEcCtD
Pentazocine—Diarrhoea—Vincristine—sarcoma	0.00331	0.00331	CcSEcCtD
Pentazocine—Sweating—Epirubicin—sarcoma	0.0033	0.0033	CcSEcCtD
Pentazocine—Nausea—Thiotepa—sarcoma	0.00324	0.00324	CcSEcCtD
Pentazocine—Feeling abnormal—Etoposide—sarcoma	0.00322	0.00322	CcSEcCtD
Pentazocine—Diarrhoea—Mitoxantrone—sarcoma	0.00322	0.00322	CcSEcCtD
Pentazocine—Nausea—Dactinomycin—sarcoma	0.00321	0.00321	CcSEcCtD
Pentazocine—Agranulocytosis—Epirubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Pentazocine—Dizziness—Vincristine—sarcoma	0.00319	0.00319	CcSEcCtD
Pentazocine—Vomiting—Vincristine—sarcoma	0.00307	0.00307	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—sarcoma	0.00305	0.00305	CcSEcCtD
Pentazocine—Dermatitis—Vincristine—sarcoma	0.00304	0.00304	CcSEcCtD
Pentazocine—Headache—Vincristine—sarcoma	0.00303	0.00303	CcSEcCtD
Pentazocine—Vomiting—Mitoxantrone—sarcoma	0.00299	0.00299	CcSEcCtD
Pentazocine—Visual impairment—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Pentazocine—Dermatitis—Mitoxantrone—sarcoma	0.00296	0.00296	CcSEcCtD
Pentazocine—Headache—Mitoxantrone—sarcoma	0.00295	0.00295	CcSEcCtD
Pentazocine—Erythema multiforme—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Pentazocine—Hypersensitivity—Etoposide—sarcoma	0.00288	0.00288	CcSEcCtD
Pentazocine—Tinnitus—Epirubicin—sarcoma	0.00288	0.00288	CcSEcCtD
Pentazocine—Nausea—Vincristine—sarcoma	0.00287	0.00287	CcSEcCtD
Pentazocine—Flushing—Epirubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Pentazocine—Asthenia—Etoposide—sarcoma	0.00281	0.00281	CcSEcCtD
Pentazocine—Nausea—Mitoxantrone—sarcoma	0.00279	0.00279	CcSEcCtD
Pentazocine—Chills—Epirubicin—sarcoma	0.00277	0.00277	CcSEcCtD
Pentazocine—Pruritus—Etoposide—sarcoma	0.00277	0.00277	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Pentazocine—Diarrhoea—Etoposide—sarcoma	0.00268	0.00268	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Pentazocine—Dysgeusia—Epirubicin—sarcoma	0.00263	0.00263	CcSEcCtD
Pentazocine—Dizziness—Etoposide—sarcoma	0.00259	0.00259	CcSEcCtD
Pentazocine—Muscle spasms—Epirubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Pentazocine—Chills—Doxorubicin—sarcoma	0.00256	0.00256	CcSEcCtD
Pentazocine—Vision blurred—Epirubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Pentazocine—Vomiting—Etoposide—sarcoma	0.00249	0.00249	CcSEcCtD
Pentazocine—Agitation—Epirubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Pentazocine—Dermatitis—Etoposide—sarcoma	0.00247	0.00247	CcSEcCtD
Pentazocine—Headache—Etoposide—sarcoma	0.00245	0.00245	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—sarcoma	0.00244	0.00244	CcSEcCtD
Pentazocine—Vertigo—Epirubicin—sarcoma	0.00241	0.00241	CcSEcCtD
Pentazocine—Syncope—Epirubicin—sarcoma	0.00241	0.00241	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Pentazocine—Loss of consciousness—Epirubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Pentazocine—Nausea—Etoposide—sarcoma	0.00232	0.00232	CcSEcCtD
Pentazocine—Hypertension—Epirubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Pentazocine—Dry mouth—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Pentazocine—Confusional state—Epirubicin—sarcoma	0.00221	0.00221	CcSEcCtD
Pentazocine—Anaphylactic shock—Epirubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—sarcoma	0.00219	0.00219	CcSEcCtD
Pentazocine—Shock—Epirubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Pentazocine—Tachycardia—Epirubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Pentazocine—Hyperhidrosis—Epirubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Pentazocine—Anorexia—Epirubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Pentazocine—Hypotension—Epirubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—sarcoma	0.00205	0.00205	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—sarcoma	0.00203	0.00203	CcSEcCtD
Pentazocine—Shock—Doxorubicin—sarcoma	0.002	0.002	CcSEcCtD
Pentazocine—Insomnia—Epirubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Pentazocine—Paraesthesia—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Pentazocine—Dyspnoea—Epirubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Pentazocine—Somnolence—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—sarcoma	0.00193	0.00193	CcSEcCtD
Pentazocine—Decreased appetite—Epirubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Pentazocine—Constipation—Epirubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Pentazocine—Feeling abnormal—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Pentazocine—Hypersensitivity—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Pentazocine—Asthenia—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Pentazocine—Pruritus—Epirubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Pentazocine—Diarrhoea—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Pentazocine—Dizziness—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Pentazocine—Vomiting—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Pentazocine—Dermatitis—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Pentazocine—Headache—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Pentazocine—Nausea—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Pentazocine—Headache—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
